Using of SGLt2 Inhibitors in Patients With Type 2 DM
To detect the efficacy of SGLT2i in improving the metabolic parameters in patients with type 2 diabetes.

- To detect the side-effects of SGLT2i
- EligibilityCriteria: Inclusion Criteria:  Adults (≥18 years) both genders ( male and female) type 2 diabetic patients  Exclusion Criteria:  history of svere hypoglycemia patients with history of weight loss Patients with history of recurrent UTI - Gender: All - MinimumAge: 18 Years - MaximumAge: 80 Years - StdAgeList: Adult, Older Adult - StudyPopulation: Adult diabetic type 2patients - SamplingMethod: Non-Probability Sample